Economic burden of guideline-discordant cervical cancer screening among commercially insured women age 15 to 20 years.
50 Background: Clinical guidelines recommend against cervical cancer screening in average-risk women younger than 21 years. Nonetheless, prior studies suggest that 13.8% of women aged 15 to 20 years still receive potentially unnecessary cervical cancer screening. We sought to estimate the costs of guideline-dis...